Ended Human Pharmacology (Phase I)- Other Nitrous oxide intoxication

Nitrous oxide detection - A study in healthy volunteers to help victims of nitrous oxide related crimes

EU CTIS ID: 2024-517234-18-00

What this study is testing

The primary objective is to investigate blood concentrations of N2O after exposure and determine how long N2O can be detected after exposure.

  • Human Pharmacology (Phase I)- Other

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Healthy volunteers aged 18-65 years
  • Informed, written consent
  • Able to understand Danish
  • Participants willing and able to use safe contraception for 24 hours day after gas exposure

You likely can't join if

  • Psychiatric and neurological: • Current or previous substance abuse, N2O abuse or alcohol abuse • A psychiatric disorder that requires medical treatment, incl. major depression • A diagnosis of epilepsy • Symptoms of peripheral neuropathy Cardiopulmonary: • Displaying symptoms of pneumothorax, pneumopericardium, bullous emphysema, gas emboli or severe cranial trauma. • Recent history of coronary artery bypass grafting (CABG) operation with extra corporeal membrane oxygenation (ECMO). • Uncontrolled asthma defined by occurrence of asthma symptoms within the last month prior to inclusion. Anesthesiological: • History of adverse reactions to anaesthesia. • Previous allergic or adverse reaction to N2O • Facial abnormalities that cause a participant to be unable to fit a nasal cannula intended for gas delivery. Occupational: • History of diving within 2 days • Inability to refrain from diving for 2 days following the experiment • Work environmental exposure to N2O • Intake of N2O within the last 3 months Interactions with medications: • Treatment with methotrexate • Treatment with benzodiazepines, opioids, or another CNS-depressant medicinal product • Treatment with physician prescribed vitamin B12 • Recent intraocular injection of gas. Gastroentestital: • Vitamin B12 deficiency • Participant with severely dilated intestines. • History of impaired hepatic or renal function Gynecological/ obstetrical: • Pregnant and breastfeeding women (Fertile women (defined as amenorrhea for less than 12 months) must have a negative HCG pregnancy test prior to intake of the trial medication)

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.